4 assets in Bile Duct Neoplasm

Therapeutic assets addressing Bile Duct Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dexasone Bile Duct Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Floxuridine Bile Duct Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
pds01adc Bile Duct Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Fapi-46 Bile Duct Neoplasm	Karolinska University Hospital	P1	CC (43)